Anthropic completed a $400 million stock acquisition of Coefficient Bio, a biotech startup operating in stealth mode
The deal represents Anthropic's strategic expansion beyond traditional AI into the biotechnology and drug discovery sectors
Coefficient Bio's focus on AI-driven biotech solutions aligns with Anthropic's broader mission to develop safe and useful AI systems
Ask the AI about this article →
For example, today's edition would include:
AI-summarized, only the topics you pick — one digest a day via Email, Slack, or Discord.
Free · takes 30 seconds · unsubscribe anytimeWhat is AIToday? →
Ask AI anything about this article. Q&As are published on this page for other readers too.
Israeli startup DataAgent Ltd
SK Hynix presented a custom HBM concept at SEMICON Taiwan 2026, where compute functions are placed in the base…
Taoyuan is positioning itself as a northern hub for AI data centers (AIDC), citing the Tatan area and an LNG c…
The U.S. Department of Defense announced on August 31 that it has deployed ChatGPT Mil, a customized version o…
Nvidia reported earnings that were both remarkable and boring, reflecting its focus on avoiding a consolidated…
Anthropic has agreed to a $35bn cloud-computing contract with Lambda, a Nvidia-backed cloud provider
